Celon Pharma SA

CLN · WAR · Healthcare / Drug Manufacturers - Specialty & Generic

15.98PLN-0.02 (-0.12%)

Price History

Full chart

Market Stats

Previous Close16.00

Open16.08

Day Range15.88 – 16.58

52-Week Range18.00 – 23.50

Volume32.75K

Market Cap1.01B

P/E (TTM)9.44

Forward P/E0.00

EPS1.98

Dividend Yield0.00%

Beta0.63

50-Day Avg20.99

200-Day Avg20.97

About

Celon Pharma S.A., an integrated pharmaceutical company, engages in the research, manufacture, and marketing of specialised generic products. The company provides drugs to treat cancers, neurological diseases, diabetes, and other metabolic disorders. Celon Pharma S.A. was founded in 2002 and is based in Lomianki, Poland. The company operates as a subsidiary of Glatton Sp. z o.o.

Company Details

SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
CEODr. Maciej Wieczorek Ph.D.
Employees560
HeadquartersOgrodowa 2A, Lomianki, Poland, 05-092, Poland
Websitehttps://www.celonpharma.com

Leadership

Dr. Maciej Wieczorek Ph.D.CEO & President of Management Board
Malgorzata StokrockaCDOO & Member of Management Board

Financials

Income Statement

Currency: PLN	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	40.11M	71.64M	98.10M	107.54M	128.78M	107.12M	125.24M	102.25M	157.45M	196.09M	161.91M	213.92M	176.62M	209.80M
Growth (%)	-	+78.61%	+36.93%	+9.62%	+19.75%	-16.82%	+16.92%	-18.36%	+53.99%	+24.54%	-17.43%	+32.12%	-17.44%	+18.79%
Cost of Revenue	7.92M	14.77M	20.26M	30.02M	28.49M	24.47M	28.18M	23.36M	32.01M	61.72M	66.46M	66.82M	63.17M	249.28M
Gross Profit	32.19M	56.87M	77.83M	77.52M	100.29M	82.65M	97.07M	78.89M	107.26M	134.37M	95.45M	147.10M	113.45M	-39.48M
Gross Margin	80.25%	79.39%	79.34%	72.08%	77.88%	77.16%	77.50%	77.16%	68.12%	68.53%	58.95%	68.76%	64.23%	-18.82%
Operating Expense	29.87M	34.90M	48.62M	30.32M	53.23M	56.66M	61.46M	71.99M	110.93M	144.82M	165.21M	174.34M	150.26M	17.28M
Operating Income	2.32M	21.97M	29.21M	47.20M	47.06M	25.99M	35.61M	6.90M	-3.67M	-10.45M	-69.76M	-27.24M	-36.81M	-56.76M
Operating Margin	5.77%	30.66%	29.78%	43.89%	36.54%	24.26%	28.43%	6.75%	-2.33%	-5.33%	-43.08%	-12.73%	-20.84%	-27.06%
EBITDA	6.65M	26.29M	34.36M	55.05M	60.82M	48.54M	55.85M	26.84M	30.37M	27.81M	9.32M	32.71M	14.96M	-10.48M
EBITDA Margin	16.59%	36.69%	35.03%	51.19%	47.23%	45.31%	44.60%	26.25%	19.29%	14.18%	5.76%	15.29%	8.47%	-4.99%
Net Income	1.33M	17.96M	52.21M	37.18M	37.81M	25.62M	29.70M	11.93M	-917.00K	-11.61M	-39.28M	-28.12M	-34.45M	-79.36M
Net Income Margin	3.32%	25.07%	53.22%	34.57%	29.36%	23.91%	23.71%	11.67%	-0.58%	-5.92%	-24.26%	-13.15%	-19.50%	-37.83%
R&D	970.00K	4.41M	8.86M	-	-	-	-	-	42.25M	49.05M	680.00K	680.00K	-	-
R&D as % of Total Revenue	2.42%	6.15%	9.03%	-	-	-	-	-	26.84%	25.02%	0.42%	0.32%	-	-
Interest Expense	260.62K	-	-	385.30K	684.58K	364.23K	1.15M	186.00K	1.42M	1.55M	1.67M	2.67M	2.47M	1.60M
Interest Expense % of Total Revenue	0.65%	-	-	0.36%	0.53%	0.34%	0.91%	0.18%	0.90%	0.79%	1.03%	1.25%	1.40%	0.76%

Balance Sheet

Currency: PLN	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	69.80M	82.59M	105.44M	168.29M	464.32M	525.05M	563.67M	591.35M	703.64M	707.14M	608.93M	569.31M	543.79M	457.46M
Total Liabilities	14.22M	30.39M	35.82M	67.47M	61.82M	85.20M	114.94M	146.31M	268.97M	153.14M	129.29M	123.75M	98.59M	74.47M
Total Equity	36.03M	52.20M	69.62M	100.82M	402.50M	439.85M	448.73M	445.04M	344.53M	554.00M	479.65M	445.56M	445.21M	363.25M
Cash	5.95M	5.68M	56.60K	2.56M	220.42M	200.94M	148.00M	66.69M	43.98M	147.80M	82.90M	32.36M	8.28M	19.31M
Total Debt	-	3.40M	5.18M	13.20M	6.25M	3.31M	954.12K	1.66M	25.48M	14.92M	26.82M	25.59M	16.93M	18.94M
Net Debt	-5.95M	-2.29M	5.12M	10.63M	-214.18M	-197.64M	-147.04M	-65.03M	-20.91M	-132.88M	-56.08M	-6.77M	8.65M	-367.00K

Cash Flow

Currency: PLN	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	12.87M	8.45M	24.36M	52.37M	20.65M	25.30M	28.24M	-5.05M	70.90M	43.95M	-4.70M	-8.31M	-11.34M	23.86M
Investing Cash Flow	-4.72M	-6.26M	-28.71M	-46.50M	-25.06M	-33.64M	-72.74M	-67.74M	-98.53M	-121.05M	-31.47M	-21.64M	-7.49M	-21.64M
Financing Cash Flow	-3.87M	-2.30M	-1.67M	-3.15M	222.39M	-11.07M	-8.85M	-8.52M	4.25M	180.91M	-28.72M	-20.59M	13.32M	-9.76M
Capital Expenditure	4.34M	5.64M	22.55M	44.86M	21.29M	31.34M	67.46M	64.95M	99.16M	41.35M	33.91M	32.81M	22.79M	54.44M
Free Cash Flow	8.52M	2.81M	1.81M	7.51M	-641.17K	-6.04M	-39.22M	-70.00M	-28.26M	2.60M	-38.61M	-41.13M	-34.13M	-30.57M
Dividends Paid	4.27M	1.79M	3.60M	5.37M	4.43M	7.65M	7.65M	7.20M	3.60M	3.15M	14.80M	4.59M	4.08M	-
FCF to OCF	66.25%	33.24%	7.44%	14.34%	-3.11%	-23.86%	-138.88%	1385.99%	-39.86%	5.92%	821.25%	494.67%	301.01%	-128.10%
Dividend Paid to FCF	50.06%	63.74%	198.76%	71.53%	-690.92%	-126.70%	-19.51%	-10.29%	-12.74%	121.15%	-38.34%	-11.17%	-11.97%	-

Earnings

Report Date	Dec 31, 2016	Mar 31, 2017	Jun 30, 2017	Sep 30, 2017	Dec 31, 2017	May 15, 2018	Sep 25, 2018	Nov 14, 2018	Mar 19, 2019	May 14, 2019	Sep 27, 2019	Nov 8, 2019	Mar 20, 2020	May 8, 2020	Sep 25, 2020	Nov 30, 2020	Mar 31, 2021	May 20, 2021	Sep 30, 2021	Nov 29, 2021	May 1, 2022	Sep 28, 2022	Nov 23, 2022	May 24, 2023	Sep 20, 2023	Nov 22, 2023	Dec 31, 2023	May 22, 2024	Jun 30, 2024	Nov 20, 2024	May 21, 2025	Sep 17, 2025	Sep 30, 2025	Dec 31, 2025	May 19, 2026	Jun 30, 2026
EPS Estimate	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.10	-0.20	-	-	-	-	-	-	-	-	-	-	-	-	-
EPS Actual	0.06	0.11	0.19	0.11	0.14	0.17	0.17	0.18	0.14	0.14	0.04	0.05	0.04	0.21	0.25	0.09	-0.07	-0.04	0.05	-0.17	-0.10	-0.01	-0.01	-0.23	0.18	-0.13	-0.29	-0.31	-0.16	1.06	-0.47	-0.62	0.07	-0.46	3.06	-0.62
Surprise	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	90.00%	95.00%	-	-	-	-	-	-	-	-	-	-	-	-	-
Timing	-	-	-	-	-	Pre-market	After-hours	Pre-market	After-hours	Pre-market	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	After-hours	-	After-hours	-	After-hours	After-hours	Pre-market	-	-	Pre-market	-

Key Statistics & Ratios

Market Cap1.01B

Enterprise Value1.14B

Trailing P/E9.44

Forward P/E0.00

Price / Sales3.91

Price / Book2.10

EPS1.98

Book Value10.10

Revenue (TTM)257.64M

Gross Profit (TTM)197.64M

EBITDA23.87M

Profit Margin41.46%

Operating Margin-17.03%

Return on Equity24.17%

Return on Assets-0.50%

Shares Outstanding53.91M

Shares Float23.82M

Beta0.63

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Dividends

20241×

0.08Jun 27, 2024

20231×

0.09Jun 29, 2023

20221×

0.29Jun 30, 2022

20211×

0.07Jul 14, 2021

20201×

0.08Jun 1, 2020

20191×

0.24Apr 29, 2019

20181×

0.17Jun 11, 2018

20171×

0.17May 31, 2017